Nanoviricides Stock Today
| NNVC Stock | USD 1.70 0.01 0.59% |
PerformanceOK
| Odds Of DistressQuite High
|
NanoViricides is trading at 1.70 as of the 23rd of July 2025, a 0.59 percent increase since the beginning of the trading day. The stock's open price was 1.69. NanoViricides has more than 69 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 24th of April 2025 and ending today, the 23rd of July 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 26th of October 2005 | Category Healthcare | Classification Health Care |
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company was founded in 2005 and is based in Shelton, Connecticut. Nanoviricides operates under Biotechnology classification in the United States and is traded on AMEX Exchange. The company has 16.07 M outstanding shares of which 242.04 K shares are now shorted by private and institutional investors with about 1.01 trading days to cover. More on NanoViricides
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
NanoViricides Stock Highlights
| Chairman | Anil Diwan | |||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||
Debt LevelsNanoViricides can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand NanoViricides' financial leverage. It provides some insight into what part of NanoViricides' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||
NanoViricides (NNVC) is traded on NYSE MKT Exchange in USA. It is located in 1 Controls Drive, Shelton, CT, United States, 06484 and employs 7 people. NanoViricides is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 27.32 M. NanoViricides conducts business under Biotechnology sector and is part of Health Care industry. The entity has 16.07 M outstanding shares of which 242.04 K shares are now shorted by private and institutional investors with about 1.01 trading days to cover.
NanoViricides currently holds about 14.07 M in cash with (6.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.21.
Check NanoViricides Probability Of Bankruptcy
Ownership AllocationNanoViricides maintains a total of 16.07 Million outstanding shares. NanoViricides secures 3.5 % of its outstanding shares held by insiders and 7.87 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check NanoViricides Ownership Details
NanoViricides Historical Income Statement
NanoViricides Stock Against Markets
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoViricides. If investors know NanoViricides will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoViricides listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NanoViricides is measured differently than its book value, which is the value of NanoViricides that is recorded on the company's balance sheet. Investors also form their own opinion of NanoViricides' value that differs from its market value or its book value, called intrinsic value, which is NanoViricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoViricides' market value can be influenced by many factors that don't directly affect NanoViricides' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoViricides' value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoViricides is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoViricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.